TCL Archive Take Program Direction Away From CCIRC, Form New Group for Clinical Trials, Conferees Suggest June 6, 1975
TCL Archive Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research April 15, 2011
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
